RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.

Envestors private network

We connect investors and scale-up companies using our suite of software and services. Through our private network, we offer screened opportunities to angel investors.

793

Deals Completed

3,981

Experienced Investors

£112,920,795

Finance Raised

  • Target

    £1,600,000

  • Type

    Equity

  • Close Date

    Dec 16 2019

  • Status

    Open

AgPlus Diagnostics

A quantitative Point of Care platform which enables faster, more accurate diagnosis and targeted treatment.

  • Sector: Healthcare
  • Region: UK: London
  • Stage: Established - substantial revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement:
  • Pre Money Valuation: £4,700,000
  • Share Price: £6.40
  • Originator: Envestors
Total Pledged: £905,005
Max

£1,600,000

  • Target

    £1,000,000

  • Type

    Equity

  • Close Date

    Dec 31 2019

  • Status

    Open

Fizzbox

Fizzbox is an online marketplace for organising or selling experiences and activities. It acts as an intermediary earning commission from each booking

  • Sector: Leisure and Entertainment
  • Region: UK: South-East
  • Stage: Early Stage - some revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £2,800,000
  • Share Price: £28.00
  • Originator: Envestors

For information please view deal

  • Target

    £1,500,000

  • Type

    Equity

  • Close Date

    Mar 31 2020

  • Status

    Open

Ablatus Limited

Ablatus Therapeutics is a MedTech company that is developing a unique tissue ablation platform - Bimodal Electric Tissue Ablation (BETA).

  • Sector: Healthcare
  • Region: UK: London
  • Stage: Other
  • Eligible Tax: EIS
  • Board Requirement:
  • Pre Money Valuation: £4,000,000
  • Share Price: £1.29
  • Originator: Envestors
Total Pledged: £600,000
Max

£1,500,000

  • Target

    £1,500,000

  • Type

    Equity

  • Close Date

    Mar 31 2020

  • Status

    Open

Art, Analysis and Research

Art, Analysis and Research (AA&R) is the leading scientific art testing company, providing art authentication and attribution reports.

  • Sector: Technology / IT / Software
  • Region: UK: London
  • Stage: Established - substantial revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Board In Place
  • Pre Money Valuation: £3,000,000
  • Share Price: £7.00
  • Originator: Envestors

For information please view deal

Preview

  • Target

    £2,000,000

  • Type

    Equity

  • Close Date

    Mar 31 2020

  • Status

    Preview

Antev

Antev Limited (Antev) is a clinical-stage biopharmaceutical company focused on the development of a drug for prostate cancer, Teverelix TFA.

  • Sector: Healthcare
  • Region: UK: London
  • Stage: Other
  • Eligible Tax: EIS
  • Board Requirement: Board In Place
  • Actual Pre Money Valuation: Undisclosed
  • Share Price: Undisclosed
  • Originator: Envestors

For information please view deal

  • Target

    £1,000,000

  • Type

    Equity

  • Close Date

    Dec 31 2019

  • Status

    Open

HotelSwaps Limited

The world’s first hotel room exchange programme that allows owners of independent luxury hotels to trade unused hotel rooms using HotelCoins®.

  • Sector: Technology / IT / Software
  • Region: UK: London
  • Stage: Established - substantial revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Undisclosed
  • Pre Money Valuation: £5,275,000
  • Share Price: £5.00
  • Originator: Envestors

For information please view deal

We are proud to be working with: